Friday, 07 August 2020

L-Day: Syngene shares soar superb

11 August 2015 | News

L-Day: Syngene shares soar superb

Dr Kiran Mazumdar-Shaw, CMD, Biocon

Dr Kiran Mazumdar-Shaw, CMD, Biocon

Shares of Syngene International, a CRO and a subsidiary of biopharmaceutical behemoth Biocon, were listed at Rs 295 today, against its issue price of Rs 250 per share, on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Its shares opened at 18% higher, and hit a high of Rs 315 on BSE, up by 26%.

In July 2015, through its Initial Public Offering (IPO), Syngene raised INR 550 crore, and was subscribed more than 32-times.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account